Analysis of variants in untranslated and promoter regions and breast cancer risk using whole genome sequencing data
View ORCID ProfileNaomi Wilcox, Jonathan P. Tyrer, Leila Dorling, Joe Dennis, Marc Naven, Mustapha Abubakar, View ORCID ProfileThomas U. Ahearn, Irene L. Andrulis, Antonis C. Antoniou, Natalia V. Bogdanova, Stig E. Bojesen, Manjeet K. Bolla, Hiltrud Brauch, Nicola J. Camp, Jenny Chang-Claude, Kamila Czene, Thilo Dörk, D. Gareth Evans, Peter A. Fasching, Jonine D. Figueroa, Henrik Flyger, Eugene J. Gardner, Anna González-Neira, Pascal Guénel, Eric Hahnen, Per Hall, Mikael Hartman, Maartje J. Hooning, Anna Jakubowska, Elza K. Khusnutdinova, Vessela N. Kristensen, View ORCID ProfileJingmei Li, Annika Lindblom, Artitaya Lophatananon, Arto Mannermaa, Siranoush Manoukian, Roger L. Milne, Rocio Nuñez-Torres, Nadia Obi, Mihalis I. Panayiotidis, Sue K. Park, John R.B. Perry, Muhammad U. Rashid, Emmanouil Saloustros, Elinor J. Sawyer, Marjanka K. Schmidt, Melissa C. Southey, Amanda B. Spurdle, Diana Torres, Qin Wang, Jacques Simard, Soo Hwang Teo, Alison M. Dunning, Peter Devilee, Douglas F. Easton
doi: https://doi.org/10.1101/2024.07.03.24309763
Naomi Wilcox
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Jonathan P. Tyrer
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Leila Dorling
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Joe Dennis
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Marc Naven
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Mustapha Abubakar
2Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
Thomas U. Ahearn
2Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
Irene L. Andrulis
3Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada
4Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada
Antonis C. Antoniou
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Natalia V. Bogdanova
5Department of Radiation Oncology, Hannover Medical School, Hannover, Germany
6Gynaecology Research Unit, Hannover Medical School, Hannover, Germany
7N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus
Stig E. Bojesen
8Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark
9Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark
10Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Manjeet K. Bolla
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Hiltrud Brauch
11Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany
12iFIT-Cluster of Excellence, University of Tübingen, Tübingen, Germany
13German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany
Nicola J. Camp
14Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA
Jenny Chang-Claude
15Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
16Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Kamila Czene
17Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Thilo Dörk
6Gynaecology Research Unit, Hannover Medical School, Hannover, Germany
D. Gareth Evans
18Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
19North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
Peter A. Fasching
20Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany
Jonine D. Figueroa
2Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
21Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK
22Cancer Research UK Edinburgh Centre, The University of Edinburgh, Edinburgh, UK
Henrik Flyger
23Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark
Eugene J. Gardner
24MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
Anna González-Neira
25Human Genotyping Unit-CeGen, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
Pascal Guénel
26Team ‘Exposome and Heredity’, CESP, Gustave Roussy, INSERM, University Paris-Saclay, UVSQ, Villejuif, France
Eric Hahnen
27Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
28Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
Per Hall
17Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
29Department of Oncology, Södersjukhuset, Stockholm, Sweden
Mikael Hartman
30Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore City, Singapore
31Department of Surgery, National University Health System, Singapore City, Singapore
32Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore
Maartje J. Hooning
33Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
Anna Jakubowska
34Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland
35International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland
Elza K. Khusnutdinova
36Institute of Biochemistry and Genetics of the Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia
37Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russia
Vessela N. Kristensen
38Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway
39Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
Jingmei Li
40Human Genetics Division, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore
Annika Lindblom
41Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
42Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden
Artitaya Lophatananon
43Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
Arto Mannermaa
44Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland
45Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland
46Biobank of Eastern Finland, Kuopio University Hospital, Kuopio, Finland
Siranoush Manoukian
47Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
Roger L. Milne
48Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia
49Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
50Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia
Rocio Nuñez-Torres
51Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
Nadia Obi
52Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
53Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Mihalis I. Panayiotidis
54Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus
Sue K. Park
55Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea
56Integrated Major in Innovative Medical Science, Seoul National University College of Medicine, Seoul, Korea
57Cancer Research Institute, Seoul National University, Seoul, Korea
John R.B. Perry
24MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
58Metabolic Research Laboratory, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
Muhammad U. Rashid
59Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
60Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan
Emmanouil Saloustros
61Department of Oncology, University Hospital of Larissa, Larissa, Greece
Elinor J. Sawyer
62School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy’s Campus, King’s College London, London, UK
Marjanka K. Schmidt
63Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands
64Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands
65Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands
Melissa C. Southey
48Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia
50Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia
66Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia
Amanda B. Spurdle
67Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Diana Torres
59Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
68Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia
Qin Wang
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Jacques Simard
69Genomics Center, Centre Hospitalier Universitaire de Québec – Université Laval Research Center, Québec City, Québec, Canada
Soo Hwang Teo
70Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia
71Department of Surgery, Faculty of Medicine, University of Malaya, UM Cancer Research Institute, Kuala Lumpur, Malaysia
Alison M. Dunning
72Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK
Peter Devilee
73Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands
74Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands
Douglas F. Easton
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
72Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK
Data Availability
Data from UK Biobank are available through application to UK Biobank. Data from the Breast Cancer Association Consortium (BCAC) used in the present study are available upon reasonable request through the BCAC Data Access Coordinating Committee. All data produced in the present study are available upon reasonable request to the authors
Posted July 05, 2024.
Analysis of variants in untranslated and promoter regions and breast cancer risk using whole genome sequencing data
Naomi Wilcox, Jonathan P. Tyrer, Leila Dorling, Joe Dennis, Marc Naven, Mustapha Abubakar, Thomas U. Ahearn, Irene L. Andrulis, Antonis C. Antoniou, Natalia V. Bogdanova, Stig E. Bojesen, Manjeet K. Bolla, Hiltrud Brauch, Nicola J. Camp, Jenny Chang-Claude, Kamila Czene, Thilo Dörk, D. Gareth Evans, Peter A. Fasching, Jonine D. Figueroa, Henrik Flyger, Eugene J. Gardner, Anna González-Neira, Pascal Guénel, Eric Hahnen, Per Hall, Mikael Hartman, Maartje J. Hooning, Anna Jakubowska, Elza K. Khusnutdinova, Vessela N. Kristensen, Jingmei Li, Annika Lindblom, Artitaya Lophatananon, Arto Mannermaa, Siranoush Manoukian, Roger L. Milne, Rocio Nuñez-Torres, Nadia Obi, Mihalis I. Panayiotidis, Sue K. Park, John R.B. Perry, Muhammad U. Rashid, Emmanouil Saloustros, Elinor J. Sawyer, Marjanka K. Schmidt, Melissa C. Southey, Amanda B. Spurdle, Diana Torres, Qin Wang, Jacques Simard, Soo Hwang Teo, Alison M. Dunning, Peter Devilee, Douglas F. Easton
medRxiv 2024.07.03.24309763; doi: https://doi.org/10.1101/2024.07.03.24309763
Analysis of variants in untranslated and promoter regions and breast cancer risk using whole genome sequencing data
Naomi Wilcox, Jonathan P. Tyrer, Leila Dorling, Joe Dennis, Marc Naven, Mustapha Abubakar, Thomas U. Ahearn, Irene L. Andrulis, Antonis C. Antoniou, Natalia V. Bogdanova, Stig E. Bojesen, Manjeet K. Bolla, Hiltrud Brauch, Nicola J. Camp, Jenny Chang-Claude, Kamila Czene, Thilo Dörk, D. Gareth Evans, Peter A. Fasching, Jonine D. Figueroa, Henrik Flyger, Eugene J. Gardner, Anna González-Neira, Pascal Guénel, Eric Hahnen, Per Hall, Mikael Hartman, Maartje J. Hooning, Anna Jakubowska, Elza K. Khusnutdinova, Vessela N. Kristensen, Jingmei Li, Annika Lindblom, Artitaya Lophatananon, Arto Mannermaa, Siranoush Manoukian, Roger L. Milne, Rocio Nuñez-Torres, Nadia Obi, Mihalis I. Panayiotidis, Sue K. Park, John R.B. Perry, Muhammad U. Rashid, Emmanouil Saloustros, Elinor J. Sawyer, Marjanka K. Schmidt, Melissa C. Southey, Amanda B. Spurdle, Diana Torres, Qin Wang, Jacques Simard, Soo Hwang Teo, Alison M. Dunning, Peter Devilee, Douglas F. Easton
medRxiv 2024.07.03.24309763; doi: https://doi.org/10.1101/2024.07.03.24309763
Subject Area
Subject Areas
- Addiction Medicine (381)
- Allergy and Immunology (699)
- Anesthesia (189)
- Cardiovascular Medicine (2832)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12531)
- Forensic Medicine (10)
- Gastroenterology (800)
- Genetic and Genomic Medicine (4409)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2838)
- Health Policy (1045)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (460)
- Neurology (4167)
- Nursing (220)
- Nutrition (615)
- Oncology (2194)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (265)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1169)
- Primary Care Research (481)
- Public and Global Health (6752)
- Radiology and Imaging (1484)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (365)
- Surgery (471)
- Toxicology (57)
- Transplantation (200)
- Urology (173)